Q1 2026 Emergent BioSolutions Inc Earnings Call Transcript

Apr 30, 2026 / 09:00 PM GMT

Release Date Price: €6.95 (+0.29%)

Transcript 10-Q8-K

Key Points

Positve

Emergent BioSolutions Inc (EBS) reported first-quarter revenue of $156 million, exceeding the high end of their guidance range.
The company has successfully reduced its net debt levels by approximately 22% in 2025, with plans for further improvement.
Emergent BioSolutions Inc (EBS) has a strong cash position, enabling the repayment of $110 million in debt last year.
The company has secured a more favorable interest rate through refinancing and established a new delayed draw term loan facility for $75 million.
International MCM revenue now represents 37% of total MCM revenues, indicating strong demand and diversification beyond the U.S. Government.

Negative

The company does not expect to repeat a large international order from 2025, which contributed significantly to revenue and EBITDA.
Adjusted gross margin is expected to be between 45% and 47%, reflecting product mix and expected pricing dynamics.
Emergent BioSolutions Inc (EBS) faces challenges in maintaining competitive pricing for Narcan while holding onto market share.
There is a significant focus on debt management and refinancing, indicating ongoing financial restructuring needs.
The geopolitical situation and potential bioterrorism threats pose risks that require continuous collaboration with governments, which may impact operational focus and resources.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EBS.N - Emergent BioSolutions Inc
Q1 2026 Emergent BioSolutions Inc Earnings Call
Apr 30, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the Q1 2026 Emergent BioSolutions Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you'll need to press *11 on your telephone. You'll then hear an automated message advising that your hand is raised. To withdraw your question, please press *11 again.

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Frank Vargo, Vice President/Treasurer. Please go ahead.

------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.